Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma

被引:0
|
作者
Setoyama, M
Kerdel, FA
Elgart, G
Kanzaki, T
Byrnes, JJ
机构
[1] Kagoshima Univ, Fac Med, Dept Dermatol, Kagoshima 890, Japan
[2] Miami Univ Med, Dept Dermatol, Miami, FL USA
[3] Miami Univ Med, Dept Med, Miami, FL USA
来源
AMERICAN JOURNAL OF PATHOLOGY | 1998年 / 152卷 / 03期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A method for nonradioactive polymerase chain reaction in situ hybridization mas developed acid used to determine the distribution of human T-lymphotropic virus type I (HTLV-I) proviral DNA in paraffin-embedded surgical specimens of adult T-cell leukemia/lymphoma (ATLL). As controls, me used biopsy samples of five cases of mycosis fungoides, cells of an HTLV-I-infected cell line (MT2), as well as HTLV-1-negative cells (YAS). We successfully detected the amplicon of the HTLV-1 tax sequence in the nuclei of the cutaneous infiltrating lymphoid cells in 90% (9/10) of ATLL cases. Studies also revealed the existence of HTLV-1 provirus DNA in nuclei of sweat gland epithelial cells and vascular endothelial cells as well as lymphoid cells in ATLL patients. Mycosis fungoides and YAS cells were negative for the HTLV-I tax sequence, but MT2 cells mere strongly positive. The results indicated that this technique mas more sensitive in detecting intracellular amplicons than was the previous in situ hybridization method. Through its use, me were able to easily determine the distribution of HTLV-I-positive cells among the various cells and tissues of paraffin-embedded archival materials.
引用
收藏
页码:683 / 689
页数:7
相关论文
共 50 条
  • [41] ADULT T-CELL LEUKEMIA LYMPHOMA (ATLL) IN BRAZIL - EVIDENCE FOR A NEW ENDEMIC AREA FOR HTLV-1
    MATUTES, E
    DEOLIVERA, MP
    SHULZ, TS
    ANDRADASERPA, MJ
    CALABRO, ML
    WEISS, R
    CATOVSKY, D
    BRITISH JOURNAL OF CANCER, 1990, 61 (06) : 948 - 948
  • [42] Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma
    Sharma, Kamal
    Janik, John E.
    O'Mahony, Deirdre
    Stewart, Donn
    Pittaluga, Stefania
    Stetler-Stevenson, Maryalice
    Jaffe, Elaine S.
    Raffeld, Mark
    Fleisher, Thomas A.
    Lee, Cathryn C.
    Urquhart, Nicole
    Steinberg, Seth
    Waldmann, Thomas A.
    Morris, John C.
    BLOOD, 2008, 112 (11) : 701 - 701
  • [43] Adult T-cell lymphoma associated with HTLV-1: An atypical case report
    de Almeida, Mariana Abdo
    de Miranda, Livia Reis
    Marchesi, Raquel Ferrari
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 (01) : 95 - 97
  • [44] PREVENTION STRATEGY OF ADULT T-CELL LEUKEMI/LYMPHOMA BY HTLV-1 ERADICATION
    Tajima, Kazuo
    ANTICANCER RESEARCH, 2014, 34 (10) : 6198 - 6200
  • [45] ADULT T-CELL LYMPHOMA HTLV-1 POSITIVE: A REPORT OF EIGHT CASES
    Vasilica, M.
    Coriu, D.
    Butca, C.
    Toma, D.
    Dobrea, C.
    Colita, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 547 - 547
  • [46] HTLV-1 INDUCED ADULT T-CELL LEUKEMIA IN NEW-ZEALAND
    SOMERFIELD, SD
    NEW ZEALAND MEDICAL JOURNAL, 1986, 99 (802) : 384 - 384
  • [47] Identification of genes upregulated in HTLV-1 induced Adult T-cell Leukemia
    Armendariz, I.
    Gibson, T.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [48] Adult T-cell leukemia induced by HTLV-1: before and after HBZ
    Dodon, Madeleine Duc
    Barbeau, Benoit
    Mesnard, Jean-Michel
    M S-MEDECINE SCIENCES, 2010, 26 (04): : 391 - 396
  • [49] Primary pulmonary hypertension associated with HTLV-1 retrovirus infection at adult T-cell leukemia lymphoma stage
    Blaquière, G
    Bolo, M
    Inamo, J
    Daoudal, P
    Delaunay, C
    Pagnot, R
    Numéric, P
    PRESSE MEDICALE, 2004, 33 (05): : 316 - 317
  • [50] Experience in the management of patients with HTLV-1 positive adult T-cell leukemia/lymphoma in a Latin American center
    Floyd-Aristizabal, Danielle
    Garcia, Cristian Alonso Barreiro
    Arias-Valderrama, Oriana
    Millan, Catalina Proano
    Perez, Nhora Maria Silva
    Martinez, Joaquin Donaldo Rosales
    Lopez, Elizabeth Arrieta
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2025, 16